FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer
F. Hoffmann-La Roche Ltd Filing acceptance is based on the phase III Alliance ATOMIC study showing Tecentriq plus…
FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer
F. Hoffmann-La Roche Ltd Filing acceptance is based on the phase III Alliance ATOMIC study showing Tecentriq plus…
Roche’s Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer
Roche RHHBY announced that the FDA has approved a label expansion for Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs)…
Roche’s Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer
Roche RHHBY announced that the FDA has approved a label expansion for Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs)…